MedTrace Logo

Early Surgery Versus Conventional Treatment in Infective Endocarditis

NCT00750373 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2015-04-23

Study results available
· View outcomes & findings →

Summary

There have been no prospective clinical studies in infective endocarditis comparing early surgery with the conventional treatment strategy based on current guidelines. The purpose of this prospective randomized trial is to compare clinical outcomes of early surgery versus conventional treatment strategy in patients with high embolic risk of infective endocarditis.

Conditions

  • Endocarditis

Interventions

PROCEDURE

Valve surgery with removal of vegetations

Early valve repair or replacement with removal of vegetations within 48 hours of randomization

Sponsors & Collaborators

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Duk-Hyun Kang, MD, PhD · Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2011-04-30
Completion
2011-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00750373 on ClinicalTrials.gov